FDA Approval for OJEMDA issued to DAY ONE BIOPHARMACEUTICALS INC
$DAWN
Biotechnology: Pharmaceutical Preparations
Health Care
New Drug Application (NDA): 217700
Company: DAY ONE BIOPHARMACEUTICALS INC
Company: DAY ONE BIOPHARMACEUTICALS INC
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
|---|---|---|---|---|---|---|---|
| OJEMDA | TOVORAFENIB | 100MG | TABLET;ORAL | Prescription | None | No | No |
| OJEMDA | TOVORAFENIB | 25MG/ML | SUSPENSION; ORAL | Prescription | None | No | No |
Original Approvals or Tentative Approvals
| Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
|---|---|---|---|---|---|---|---|
| 04/23/2024 | ORIG-1 | Approval | Type 1 - New Molecular Entity | PRIORITY; Orphan |
Label (PDF)
|
https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/217700s000lbl.pdf |
| Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert |
Note | Url |
|---|---|---|---|---|---|
| 04/23/2024 | ORIG-1 | Approval | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/217700s000lbl.pdf |